Related Experiment Videos
Decrease of the spontaneous non-quantal release of acetylcholine from the phrenic nerve in botulinum-poisoned rat
Pflugers Archiv : European Journal of Physiology
|June 1, 1983
Summary
Botulinum type A toxin (BoTx) reduces acetylcholine (ACh) release from normal rat diaphragms. This neurotoxin inhibits non-quantal ACh release from motor nerve terminals, impacting neuromuscular junctions.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Spontaneous acetylcholine (ACh) release occurs at neuromuscular junctions.
- Botulinum type A toxin (BoTx) is known to affect neurotransmitter release.
Purpose of the Study:
- To investigate the effect of Botulinum type A toxin (BoTx) on non-quantal acetylcholine (ACh) release from rat diaphragms.
- To determine the mechanism and site of action of BoTx on ACh release.
Main Methods:
- Incubation of normal and chronically denervated rat diaphragms.
- Measurement of spontaneous ACh release in the presence of K+.
- Assessment of membrane potential changes and tubocurarine's effect after cholinesterase inhibition and BoTx administration.
Main Results:
- BoTx diminished spontaneous ACh release by 40% in normal rat diaphragms.
- BoTx did not affect ACh release in chronically denervated diaphragms.
- BoTx rapidly abolished depolarization and altered the H-response in anticholinesterase-treated muscles, suggesting action on nerve terminals.
Conclusions:
- Botulinum type A toxin (BoTx) inhibits non-quantal acetylcholine (ACh) release from motor nerve fibers.
- BoTx likely acts directly on the nerve terminal surface membrane.
- The H-response in rat diaphragms reflects non-quantal ACh release from nerve terminals.